{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:15:53Z","timestamp":1762078553858},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.clindermatol.2003.12.031","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T17:36:16Z","timestamp":1085852176000},"page":"76-81","source":"Crossref","is-referenced-by-count":23,"title":["Botulinum neurotoxin for the treatment of migraine and other primary headache disorders"],"prefix":"10.1016","volume":"22","author":[{"given":"David","family":"Dodick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.12.031_BIB1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.57.3.418","article-title":"The global burden of disease study","volume":"57","author":"Menken","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States","volume":"159","author":"Hu","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB4","first-page":"255","article-title":"Economic costs of neoplasms, arteriosclerosis, and diabetes in the United States","volume":"10","author":"Thom","year":"1996","journal-title":"In Vivo"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJM199203263261304","article-title":"An economic evaluation of asthma in the United States","volume":"326","author":"Weiss","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","article-title":"Migraine","volume":"346","author":"Goadsby","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1526-4610.1998.3807497.x","article-title":"Prevalence of frequent headache in a population sample","volume":"38","author":"Scher","year":"1998","journal-title":"Headache"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","article-title":"Migraine","volume":"22","author":"Silberstein","year":"2002","journal-title":"Cephalalgia"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2003.12.031_BIB10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/PL00007818","article-title":"Evidence-based medicine","volume":"248","author":"Gobel","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB11","unstructured":"Botox\u00ae (botulinum toxin type A) prescribing information. Irvine, CA: Allergan Pharmaceuticals"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin A for axillary hyperhidrosis (excessive sweating)","volume":"344","author":"Heckmann","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1064-7406(23)00395-4","article-title":"Botulinum toxin (Botox) chemodenervation for facial rejuvenation","volume":"9","author":"Carruthers","year":"2001","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.58.2.232","article-title":"Treatment of chronic limb spasticity with botulinum toxin A","volume":"58","author":"Dunne","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/mda.2001.25964","article-title":"Complications and adverse reactions with the use of botulinum toxin","volume":"48","author":"Klein","year":"2002","journal-title":"Dis Mon"},{"issue":"suppl 6","key":"10.1016\/j.clindermatol.2003.12.031_BIB17","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin","volume":"20","author":"Brin","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB19","unstructured":"Aoki R. The antinociceptive mechanism of action of botulinum toxin A. Presented at the American Headache Society's 44th Annual Scientific Meeting, Seattle, WA, June 2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","article-title":"An association between migraine and cutaneous allodynia","volume":"47","author":"Burstein","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (Botox) for treatment of migraine headaches","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB22","first-page":"422","article-title":"Botulinum toxin A is an effective prophylactic therapy for migraines","volume":"20","author":"Mauskop","year":"2000","journal-title":"Cephalagia"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB23","unstructured":"Eross EG, Dodick DW. The effects of botulinum toxin type A on disability in episodic and chronic migraine. Neurology 2002;58(suppl 3):A497"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB24","unstructured":"Blumenfeld A. Botulinum toxin type A (Botox) as an effective prophylactic treatment in headache [abstract 81]. Presented at the 6th Headache Congress, European Headache Federation, Istanbul, Turkey, June 26-30, 2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11916-002-0054-1","article-title":"The use of botulinum toxin in the treatment of headaches","volume":"6","author":"Mauskop","year":"2002","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB26","unstructured":"Mauskop A. Long-term use of botulinum toxin type A (Botox) in the treatment of episodic and chronic migraine headaches [abstract S105]. Presented at the American Headache Society's 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB27","unstructured":"Mathew NT, Kallasam J, Kaupp A, et al. Disease modification in chronic migraine with botulinum toxin type A: long-term experience [abstract S107]. Presented at the American Headache Society's 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB28","unstructured":"Miller T, Denny L. Retrospective cohort analysis of 48 chronic headache patients treated with botulinum toxin type A (Botox) in a combination fixed-injection-site and \u201cfollow the pain\u201d protocol [abstract S138]. Presented at the American Headache Society's 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB29","unstructured":"Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (Botox) in the prophylactic treatment of migraine [abstract S106]. Presented at the American Headache Society's 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB30","series-title":"Scientific and therapeutic aspects of botulinum toxin","first-page":"233","article-title":"Botulinum toxin type A for pain and headache","author":"Brin","year":"2002"},{"key":"10.1016\/j.clindermatol.2003.12.031_BIB31","unstructured":"Ondo WG, Vuong KD, Derman HS. Botulinum toxin A (Botox) for chronic daily headache: a randomized placebo-controlled, parallel design study [abstract S131]. Presented at the American Headache Society's 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T14:47:14Z","timestamp":1705157234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0738081X03001536"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.12.031","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}